MIE yields 198.39% · MRK yields 2.81%● Live data
📍 MIE pulled ahead of the other in Year 1
Combined, MIE + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MIE + MRK for your $10,000?
Cohen & Steers MLP Income & Energy Opportunity Fund, formerly Cohen & Steers MLP Income and Energy Opportunity Fund, Inc., is a non-diversified, closed-end management investment company. The Fund's investment objective is to provide attractive total return, consisted of high current income and price appreciation. Under normal market conditions, the Fund will invest at least 80% of its managed assets in energy-related master limited partnerships (MLPs) and companies that are involved in the exploration, production, gathering, transportation, processing, storage, refining, distribution or marketing of natural gas, natural gas liquids (including propane), crude oil, refined petroleum products, coal or other energy sources. The Fund also invests in marine shipping/offshore, chemicals, finance, real estate-diversified, technology-software, utilities, integrated telecommunications services and pipelines. Cohen & Steers Capital Management, Inc. is the investment advisor of the Fund.
Full MIE Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.